Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Charles Drew Nclex Deferral topic

No spam. Unsubscribe anytime.

Committee defers action on Charles Drew University BSN after NCLEX pass-rate shortfall

2185420 · January 31, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

A continuing-approval visit found an NCLEX pass-rate shortfall for Charles Drew University's baccalaureate nursing program. The Education Licensing Committee deferred action and asked for progress reporting; the program reported a 68.42% first-time pass rate and expects to meet the 75% threshold by 2026.

The Education Licensing Committee deferred taking final action on the continuing approval status of Charles Drew Universitybaccalaureate nursing program after a continuing-approval visit identified a single area of noncompliance: NCLEX first-time pass rates below the regulatory threshold.

Why it matters: the Board's continuing-approval process is designed to ensure program quality and public protection. The committee deferred action to allow the program time to implement corrective measures and to report outcomes to the Board when updated NCLEX data are available.

What happened: Mary Anne McCarthy, the BRN's supervising nursing education consultant and liaison to the committee, summarized the continuing-approval visit and its findings. McCarthy told the committee the programwhich graduated its first cohort in summer 2023reported a first-time NCLEX pass rate of "68.42%" for the 202324 cohort. McCarthy said the program has submitted a progress report and an executive summary of corrective actions and "anticipates that they will come into compliance in 2026."

Program response: Program representatives described steps they have taken since the low pass rate was reported. The Charles Drew delegation said they have increased individualized student supports, added testing coaching, reorganized course sequencing to strengthen clinical judgment and dosage calculation earlier in the curriculum, and expanded faculty coaching and outreach to graduates to reduce test-delay behavior. Program representatives emphasized data-driven curricular adjustments and additional student remediation and post-graduate coaching.

Committee action: Committee Chair Jovita Dominguez moved to defer taking action on the continuing approval status while the program works to clear areas of noncompliance and to return to the Board in January/February 2026. A committee member seconded the motion. The roll-call vote recorded Dominguez yes, Dolores Trujillo yes, and Tricia Winn yes. The motion carried.

Follow-up and timing: Staff and the committee noted the timing constraints intrinsic to NCLEX data: the Board receives annual pass-rate data later in the summer, programs need time to graduate and test before results can show improvement, and outcomes are typically validated in the following year's reporting cycle. The committee asked the program to provide progress reporting and left open quarterly NEC communication; staff said they will report back to the committee and Board when the updated pass-rate outcomes are available.

Ending: The committee deferred any change in the program's approval status rather than imposing immediate sanction. The program will provide ongoing progress reports to NEC staff and return to the full Board in early 2026 when updated NCLEX outcomes are expected.